查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1471968

神经调节设备市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用、生物材料和最终用户

Neuromodulation Devices Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Biomaterial, and End User
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

根据我们关于「2030 年神经调节设备市场预测 - 全球和地区份额、趋势和成长机会分析 - 按类型、应用、生物材料和最终用户」的最新研究，2022 年市场估值为 57.3 亿美元，预计到2030年将达116.1亿美元；预计2022年至2030年复合年增长率为9.2%。

神经调节装置是一种可以调节神经系统活动的先进医疗仪器。此技术用于治疗肌张力失调、帕金森氏症、震颤等运动障碍；耳鸣;强迫症;感觉障碍；癫痫;膀胱控制；头痛;慢性疼痛;中风;最低意识状态；痉挛;和脊髓损伤。

据世界卫生组织称，2022年，美国将记录5,000万例癫痫病例、10亿例偏头痛病例和40万例脊髓损伤病例。脊髓刺激是治疗慢性背痛最优选的技术之一，主要是由于脊髓神经控制疼痛感的解剖学和功能能力。脊髓损伤的发生率在过去十年中有所增加。国家脊髓损伤统计中心 (NSCISC) 2021 年情况说明书指出，脊髓损伤的年发生率为每百万人 60 例。根据2022年4月发表的题为《创伤性脊髓损伤的流行病学：一项基于大规模人群的研究》的文章，创伤性脊髓损伤的总体年龄-性别标准化发病率为每100万人口中26.5例，发病率为与两性的年龄有关。根据同一来源，在老年人口（≥65岁）中，男性和女性的发生率分别为每100万中59.2人和23.3人。脊髓刺激器可用于控制与脊椎手术相关的术后疼痛。脊髓手术数量的增加推动了对脊髓刺激器的需求。因此，老年人和成年人脊髓损伤的高发生率刺激了对神经调节装置的需求。

按应用划分，神经调节设备市场洞察

神经调节设备市场依应用分为深部脑部刺激（DBS）、荐神经刺激（SNS）、胃电刺激（GES）、脊髓刺激（SCS）和迷走神经刺激（VNS）。脊髓刺激细分市场在 2022 年占据最大市场份额，预计 2022 年至 2030 年期间将创下市场最高复合年增长率。脊髓刺激已使用多年，并被建议用于越来越多的病症。此疗法可帮助治疗颈椎和腰椎神经根炎、背部手术失败症候群、复杂区域疼痛症候群和神经病变。脊髓刺激在慢性疼痛治疗​​中有效、安全且具有成本效益。较新的脊髓刺激技术正在扩大内臟疼痛和缺血性疼痛等临床适应症，并有可能进一步提高疗效。

透过生物材料、神经调节设备市场的见解

根据生物材料，神经调节设备市场分为金属、聚合物和陶瓷。 2022年，金属细分市场占据市场份额。然而，聚合物细分市场可能在 2022 年至 2030 年期间实现最高的复合年增长率。在神经调节装置中，经常使用金属生物材料，特别是在电极和其他需要高度耐用和导电的部件中。由于其巨大的强度重量比和卓越的生物相容性，钛及其合金经常用于神经调节装置。

疾病管制与预防中心以及巴西神经科学和神经技术研究所是在准备神经调节设备市场报告时提到的一些主要的一手和二手来源。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解
  • 市场吸引力分析

第 3 章：研究方法

第 4 章：神经调节设备市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链供应商名单

第 5 章：神经调节设备市场 - 主要市场动态

  • 主要市场驱动因素
  • 主要市场限制
  • 主要市场机会
  • 未来的趋势
  • 驱动因素和限制因素的影响分析

第 6 章：神经调节设备市场 - 全球市场分析

  • 神经调节设备 - 全球市场概览
  • 神经调节设备 - 全球市场与 2030 年预测

第 7 章：神经调节设备市场 - 收入分析 - 按类型，2020-2030 年

  • 概述
  • 内部的
  • 外部的

第 8 章：神经调节设备市场 - 收入分析 - 按应用划分，2020-2030 年

  • 概述
  • 深部脑部刺激 (DBS)
  • 胃电刺激 (GES)
  • 脊髓刺激 (SCS)
  • 迷走神经刺激 (VNS)
  • 荐神经刺激 (SNS)

第 9 章：神经调节设备市场 - 收入分析 - 按生物材料，2020-2030 年

  • 概述
  • 金属色
  • 聚合
  • 陶瓷製品

第 10 章：神经调节设备市场 - 收入分析 - 按最终用户，2020-2030 年

  • 概述
  • 医院
  • 诊所
  • 家庭医疗保健

第 11 章：神经调节设备市场 - 收入分析，2020-2030 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

註 - 将为以下提到的地区/国家提供类似的分析

  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第13章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与专注

第 14 章：神经调节设备市场 - 主要公司简介

  • Boston Scientific Corporation
  • Abbott
  • LivaNova PLC
  • Nevro Corp
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • Synapse Biomedical Inc.
  • Aleva Neurotherapetics SA
  • Bioventus
  • EnteroMedics Inc

第 15 章：附录

简介目录
Product Code: TIPRE00018069

According to our latest study on "Neuromodulation Devices Market Forecast to 2030 - Global and Regional Share, Trend, and Growth Opportunity Analysis - by Type, Application, Biomaterial, and End User," the market was valued at US$ 5.73 billion in 2022 and is expected to reach US$ 11.61 billion by 2030; it is estimated to register a CAGR of 9.2% from 2022 to 2030.

Neuromodulation devices are advanced medical instruments that can adjust the activity of the nervous system. The technology is used to treat movement disorders such as dystonia, Parkinson's disease, and tremor; tinnitus; obsessive-compulsive disorder; sensory disabilities; epilepsy; bladder control; headache; chronic pain; stroke; minimally conscious state; spasticity; and spinal cord injury.

According to the WHO, in 2022, the US recorded 50 million epilepsy cases, 1 billion migraine cases, and 400,000 spinal cord injury cases. Spinal cord stimulation is one of the most preferred techniques in treating chronic back pain, primarily due to the anatomical and functional abilities of the spinal cord nerves to control the sensation of pain. The incidence of spinal cord injuries has grown over the past decade. The National Spinal Cord Injury Statistical Center (NSCISC) 2021 fact sheet states that the annual incidence of spinal cord injuries is 60 cases per million. According to the article titled "Epidemiology of traumatic spinal cord injuries: a large population-based study," published in April 2022, the overall age-sex standardized incidence rate of traumatic spinal cord injuries was 26.5 per 1 million population, and the rates were related to age in both sexes. According to the same source, in elderly (>= 65 years) population, the rate is 59.2 and 23.3 per 1 million in males and females, respectively. Spinal cord stimulators can be useful in managing postoperative pain associated with spinal surgery. An increase in number of spinal cord surgeries propels the demand for spinal cord stimulators. Therefore, high incidence of spinal cord injuries in old age and adults stimulates the demand for neuromodulation devices.

By Application, Neuromodulation Devices Market-Based Insights

The neuromodulation devices market, by application, is segmented into deep brain stimulation (DBS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). The spinal cord stimulation segment held the largest market share in 2022 and is expected to record the highest CAGR in the market during 2022-2030. Spinal cord stimulation has been used for years and is advised for a growing number of conditions. Cervical and lumbar radiculitis, failed back surgery syndrome, complex regional pain syndrome, and neuropathy are a few conditions that the therapy can assist. Spinal cord stimulation is efficacious, safe, and cost effective in chronic pain management. Newer spinal cord stimulation technologies are expanding clinical indications such as visceral and ischemic pain, with potential for further improved efficacy.

By Biomaterial, Neuromodulation Devices Market -Based Insights

Based on biomaterial, the neuromodulation devices market is segmented into metallic, polymeric, and ceramic. In 2022, the metallic segment dominated the market share. However, the polymeric segment is likely to register the highest CAGR during 2022-2030. In neuromodulation devices, metallic biomaterials are frequently utilized, especially in electrodes and other parts that need to be highly durable and electrically conductive. Owing to their great strength-to-weight ratio and exceptional biocompatibility, titanium and its alloys are frequently used in neuromodulation devices.

Center for Disease Control and Prevention, and Brazilian Institute of Neuroscience and Neurotechnology are a few of the major primary and secondary sources referred to while preparing the report on the neuromodulation devices market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Neuromodulation Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Neuromodulation Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Neuromodulation Devices Market - Global Market Analysis

  • 6.1 Neuromodulation Devices - Global Market Overview
  • 6.2 Neuromodulation Devices - Global Market and Forecast to 2030

7. Neuromodulation Devices Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 7.1 Overview
  • 7.2 Internal
  • 7.3 External

8. Neuromodulation Devices Market - Revenue Analysis (USD Million) - By Application, 2020-2030

  • 8.1 Overview
  • 8.2 Deep Brain Stimulation (DBS)
  • 8.3 Gastric Electrical Stimulation (GES)
  • 8.4 Spinal Cord Stimulation (SCS)
  • 8.5 Vagus Nerve Stimulation (VNS)
  • 8.6 Sacral Nerve Stimulation (SNS)

9. Neuromodulation Devices Market - Revenue Analysis (USD Million) - By Biomaterial, 2020-2030

  • 9.1 Overview
  • 9.2 Metallic
  • 9.3 Polymeric
  • 9.4 Ceramic

10. Neuromodulation Devices Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 10.1 Overview
  • 10.2 Hospitals
  • 10.3 Clinics
  • 10.4 Home Healthcare

11. Neuromodulation Devices Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Neuromodulation Devices Market Overview
    • 11.1.2 North America Neuromodulation Devices Market Revenue and Forecasts to 2030
    • 11.1.3 North America Neuromodulation Devices Market Revenue and Forecasts and Analysis - By Type
    • 11.1.4 North America Neuromodulation Devices Market Revenue and Forecasts and Analysis - By Application
    • 11.1.5 North America Neuromodulation Devices Market Revenue and Forecasts and Analysis - By Biomaterial
    • 11.1.6 North America Neuromodulation Devices Market Revenue and Forecasts and Analysis - By End User
    • 11.1.7 North America Neuromodulation Devices Market Revenue and Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Neuromodulation Devices Market
        • 11.1.7.1.1 United States Neuromodulation Devices Market, by Type
        • 11.1.7.1.2 United States Neuromodulation Devices Market, by Application
        • 11.1.7.1.3 United States Neuromodulation Devices Market, by Biomaterial
        • 11.1.7.1.4 United States Neuromodulation Devices Market, by End User
      • 11.1.7.2 Canada Neuromodulation Devices Market
        • 11.1.7.2.1 Canada Neuromodulation Devices Market, by Type
        • 11.1.7.2.2 Canada Neuromodulation Devices Market, by Application
        • 11.1.7.2.3 Canada Neuromodulation Devices Market, by Biomaterial
        • 11.1.7.2.4 Canada Neuromodulation Devices Market, by End User
      • 11.1.7.3 Mexico Neuromodulation Devices Market
        • 11.1.7.3.1 Mexico Neuromodulation Devices Market, by Type
        • 11.1.7.3.2 Mexico Neuromodulation Devices Market, by Application
        • 11.1.7.3.3 Mexico Neuromodulation Devices Market, by Biomaterial
        • 11.1.7.3.4 Mexico Neuromodulation Devices Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 Italy
    • 11.2.4 Spain
    • 11.2.5 United Kingdom
    • 11.2.6 Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1 Australia
    • 11.3.2 China
    • 11.3.3 India
    • 11.3.4 Japan
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 Middle East and Africa
    • 11.4.1 South Africa
    • 11.4.2 Saudi Arabia
    • 11.4.3 U.A.E
    • 11.4.4 Rest of Middle East and Africa
  • 11.5 South and Central America
    • 11.5.1 Brazil
    • 11.5.2 Argentina
    • 11.5.3 Rest of South and Central America

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Neuromodulation Devices Market - Key Company Profiles

  • 14.1 Boston Scientific Corporation
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies

  • 14.2 Abbott
  • 14.3 LivaNova PLC
  • 14.4 Nevro Corp
  • 14.5 NeuroPace, Inc.
  • 14.6 NeuroSigma, Inc.
  • 14.7 Synapse Biomedical Inc.
  • 14.8 Aleva Neurotherapetics SA
  • 14.9 Bioventus
  • 14.10 EnteroMedics Inc

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud